M. Eileen Dolan
M. Eileen Dolan
Professor of Medicine, University of Chicago
Dirección de correo verificada de medicine.bsd.uchicago.edu
TítuloCitado porAño
Molecular mechanisms of resistance and toxicity associated with platinating agents
CA Rabik, ME Dolan
Cancer treatment reviews 33 (1), 9-23, 2007
Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS
DL Nicolae, E Gamazon, W Zhang, S Duan, ME Dolan, NJ Cox
PLoS genetics 6 (4), 2010
The gene ontology (GO) project in 2006
Gene Ontology Consortium
Nucleic acids research 34 (suppl_1), D322-D326, 2006
The gene ontology project in 2008
Gene Ontology Consortium
Nucleic acids research 36 (suppl_1), D440-D444, 2008
Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase
AE Pegg, ME Dolan, RC Moschel
Progress in nucleic acid research and molecular biology 51, 167-223, 1995
Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against …
ME Dolan, RC Moschel, AE Pegg
Proceedings of the National Academy of Sciences 87 (14), 5368-5372, 1990
Gene Ontology annotations and resources
Gene Ontology Consortium
Nucleic acids research 41 (D1), D530-D535, 2012
The Gene Ontology in 2010: extensions and refinements
Gene Ontology Consortium
Nucleic acids research 38 (suppl_1), D331-D335, 2010
Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2
R Humerickhouse, K Lohrbach, L Li, WF Bosron, ME Dolan
Cancer research 60 (5), 1189-1192, 2000
High-throughput discovery of novel developmental phenotypes
ME Dickinson, AM Flenniken, X Ji, L Teboul, MD Wong, JK White, ...
Nature 537 (7621), 508-514, 2016
The gene ontology resource: 20 years and still GOing strong
Gene Ontology Consortium
Nucleic acids research 47 (D1), D330-D338, 2019
Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents
ME Dolan, RB Mitchell, C Mummert, RC Moschel, AE Pegg
Cancer research 51 (13), 3367-3372, 1991
AgBase: a functional genomics resource for agriculture
FM McCarthy, N Wang, GB Magee, B Nanduri, ML Lawrence, EB Camon, ...
BMC genomics 7 (1), 229, 2006
O6-benzylguanine and its role in chemotherapy.
ME Dolan, AE Pegg
Clinical Cancer Research 3 (6), 837-847, 1997
The pharmacogenetics research network: from SNP discovery to clinical drug response
KM Giacomini, CM Brett, RB Altman, NL Benowitz, ME Dolan, ...
Clinical Pharmacology & Therapeutics 81 (3), 328-345, 2007
SCAN: SNP and copy number annotation
ER Gamazon, W Zhang, A Konkashbaev, S Duan, EO Kistner, DL Nicolae, ...
Bioinformatics 26 (2), 259-262, 2010
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer
EE Vokes, MS Kies, DJ Haraf, K Stenson, M List, R Humerickhouse, ...
Journal of Clinical Oncology 18 (8), 1652-1661, 2000
Testicular cancer survivorship: research strategies and recommendations
LB Travis, C Beard, JM Allan, AA Dahl, DR Feldman, J Oldenburg, ...
Journal of the National Cancer Institute 102 (15), 1114-1130, 2010
Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics
F Innocenti, DL Kroetz, E Schuetz, ME Dolan, J Ramírez, M Relling, ...
Journal of Clinical Oncology 27 (16), 2604, 2009
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.
HS Friedman, DM Kokkinakis, J Pluda, AH Friedman, I Cokgor, ...
Journal of clinical oncology 16 (11), 3570-3575, 1998
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20